Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
Taiwan · Delayed Price · Currency is TWD 56.80
+1.00 (1.79%)
Apr 20, 2026, 12:57 PM CST
TPEX:6864 Market Cap
TPEX:6864 has a market cap or net worth of 1.82 billion as of April 20, 2026. Its market cap has decreased by -52.63% in one year.
Market Cap
1.82B
Enterprise Value
1.62B
Revenue
612.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
56.80
Market Cap Chart
Since December 29, 2021, TPEX:6864's market cap has increased from 1.50B to 1.82B, an increase of 21.03%. That is a compound annual growth rate of 4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.82B | -35.27% |
| Dec 31, 2025 | 2.80B | 42.37% |
| Dec 31, 2024 | 1.97B | 210.82% |
| Dec 29, 2023 | 633.75M | -17.29% |
| Dec 30, 2022 | 766.25M | -45.27% |
| Dec 30, 2021 | 1.40B | -6.67% |
| Dec 29, 2021 | 1.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 2.38B |
| Chunghwa Chemical Synthesis & Biotech | 2.26B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.16B |
| Sunny Pharmtech | 2.13B |
| Synbio Tech | 2.04B |
| TaiRx | 1.99B |
| GenMont Biotech Incorporation | 1.54B |
| Advagene Biopharma | 1.53B |